Therapy of Hypertension Flashcards
What are the non-drug causes of secondary hypertension?
1) Chronic kidney disease
2) Cushing’s syndrome
3) Coarctation of the aorta
4) Obstructive sleep apnea
5) Primary hyperparathyroidism
6) Pheochromocytoma
7) Primary aldosteronism
8) Renovascular disease.
9) Thyroid disease (both hypo- and hyper-thyroidism)
Which drugs can cause secondary hypertension? !!!
1) Amphetamines
2) Antivascular endothelial growth factor agents.
3) Corticosteroids
4) Calcineurin inhibitors
5) Decongestants
6) Ergot alkaloids
7) Erythropoiesis-stimulating agents
8) Estrogen-containing oral contraceptives
9) NSAIDs
10) β-blocker withdrawal
11) Tyramine-containing foods
12) Street drugs
13) Alcohol
14) Licorice
Which drugs are anti-vascular endothelial growth factors?
1) Bevacizumab
2) Ranibizumab
3) Aflibercept
Which drugs are Calcineurin inhibitors?
1) Cyclosporine
2) Tacrolimus
Which drugs are decongestants?
1) Pseudoephedrine
2) Phenylephrine
Which drugs are Ergot alkaloids?
1) Bromocriptine
2) Methysergide
3) Dihydroergotamine
Which drugs are Erythropoiesis-stimulating agents?
1) Erythropoietin
2) Darbepoetin
What is the first step in management of secondary hypertension?
Removing the offending agent or treating/correcting the underlying co-morbid condition
Hypertensive crises (>180/>120) are categorized into:
1) Hypertensive emergency
2) Hypertensive urgency
What is a hypertensive emergency?
Extreme BP elevations that are accompanied by acute or progressing end-organ damage
What is a hypertensive urgency?
Extreme BP elevations without acute or progressing end-organ injury
The specific selection of antihypertensive drug therapy should be based on:
Evidence demonstrating CV event reduction
According to JNC8, the BP goal for ages ≥ 60 years is:
< 150/90
According to JNC8, the BP goal for ages < 60 years is:
< 140/90
Treating patients to lower BP goals may lead to:
1) Hypotension
2) Syncope
3) Electrolyte abnormalities
4) Acute kidney injury or failure
What is the main reason for poor BP control rates?
“Clinical Inertia”
What is “Clinical Inertia”?
A clinic visit at which NO therapeutic move was made to lower BP in a patient with uncontrolled hypertension
After the diagnosis of hypertension, most patients should be placed on:
Both life-style modifications and drug therapy
After the diagnosis of pre-hypertension, most patients should be placed on:
Life-style modifications
The choice of initial antihypertensive drug therapy depends on:
1) Degree of BP elevation
2) Presence of compelling indication
Most patients with stage 1 hypertension should be initially treated with a first-line drug or the combination of two, which are:
Monotherapy:
1) ACEi
2) ARB
3) CCB
4) Thiazide diuretic
Two-drug combination:
ACEi or ARB + CCB or thiazide diuretic.
For patients with stage 2 hypertension, combination drug therapy is recommended, using preferably two first-line antihypertensive drugs, such as:
1) ACEi or ARB + CCB
2) ACEi or ARB + thiazide
Life-style modifications should never be used as:
A replacement for antihypertensive drug therapy
Which lifestyle modifications should pre-hypertensive and hypertensive patients follow?
1) Gradual weight loss
2) Diet
3) Reduced salt intake
4) Aerobic physical activity
5) Moderation of alcohol intake
6) Smoking cessation
7) Control of diabetes and dyslipidemia
Maximum sodium intake should be:
2400 mg/day
Why are the first-line drugs chosen?
Because of evidence demonstrating cardiovascular event reduction
β-Blocker therapy should be reserved to either:
1) Treat a specific compelling indication
OR
2) Used in combination with one or more of the first-line antihypertensive agents for patients without a compelling indication
When can β-blockers be used as first-line antihypertensive agents?
When an ACEi, ARB, CCB, or thiazide can NOT be used as the first-line agent.
Alternative antihypertensive drug classes may be used in select patients after first-line agents, such as:
1) Loop diuretics
2) Potassium sparing diuretics
3) β-blockers
4) α1-blockers
5) Central α2-agonists
6) Direct renin inhibitors
7) Direct arterial vasodilator (hydralazine)
What drug therapy is used for patients with compelling indications?
Drug combination
Systolic heart failure is associated with:
Decreased cardiac output
Which antihypertensives are indicated in heart failure with reduced ejection fraction?
1) Low dose ACEi or ARB
+
2) Diuretic therapy
+
3) Low dose β-blocker (Bisoprolol, Carvedilol, or Metoprolol)
±
4) Aldosterone receptor antagonist
Why low dose ACEi/ARBs in heart failure with reduced ejection fraction?
Heart failure induces a compensatory high-renin condition = profound first-dose effect and possible orthostatic hypotension.
Which drug relieves edema in heart failure with reduced ejection fraction?
Diuretics
____ are often needed, especially for patients with more advanced heart failure and/or CKD.
Loop diuretics
Which β-blockers are the only ones proven to be beneficial in heart failure with reduced ejection fraction?
1) Bisoprolol
2) Carvedilol
3) Sustained-release Metoprolol
The addition of an aldosterone antagonist (spironolactone or eplerenone) in heart failure with reduced ejection fraction can reduce:
Cardiovascular morbidity and mortality
What are the first choices to decrease cardiac adrenergic stimulation post-MI?
1) β-Blockers (without intrinsic sympathomimetic activity)
2) ACEi or ARB
Why are β-Blockers and ACEi or ARB the first choice post-MI?
They reduce the risk of a subsequent MI or sudden cardiac death
ACEi treatment post-MI:
1) Improves cardiac remodeling and function
2) Reduces cardiovascular events
What should be used first post-MI: β-Blockers or ACEi/ARBs?
β-blockers
What are the most common hypertension-associated complications?
1) Chronic stable angina
2) Acute coronary syndrome (unstable angina and acute MI)
___ is a standard of care for treating hypertension-associated complications.
β-Blocker therapy
β-Blocker therapy is the first-line therapy in chronic stable angina and have the ability to:
Reduce BP and improve ischemic symptoms by decreasing myocardial oxygen consumption and demand.
Which drugs are alternatives to β-blockers in hypertension-associated complications?
Long-acting CCBs
What are the long-acting CCBs?
The Non-dihydropyridines:
1) Diltiazem
2) Verapamil
____ are considered as add-on therapy in chronic stable angina for patients with ischemic symptoms.
Dihydropyridine CCBs
Thiazides can be added to the therapy of Coronary Artery Disease to:
1) Provide additional BP lowering
2) Further reduce cardiovascular risk
Do thiazides provide anti-ischemic effects?
NO
___ have been shown to reduce CV events in patients with diabetes.
ACEi/ARB
ACEi/ARBs provide ___ due to vasodilation in the efferent arteriole.
Nephro-protection
___ are the most appropriate add-on agents for BP control for patients with diabetes.
CCBs
ACEi/ARBs provide nephro-protection due to:
Vasodilation in the efferent arteriole
What problems do diabetic patients face when using β-Blockers?
1) Masking hypoglycemia signs & symptoms
2) Delay in hypoglycemia recovery time
3) Acutely elevated BP due to
vasoconstriction during hypoglycemia recovery
Which physiologic function still occurs during a hypoglycemic episode despite β-blocker therapy?
Sweating
Which type of β-blockers are used in diabetic patients?
Selective